Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date | Purpose |
|---|---|---|---|---|---|
| Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) | PAR-21-279 | NCI | The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NCI R25 program is to support educational activities… More | ||
| NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) | PAR-20-292 | NCI | This Funding Opportunity Announcement (FOA) supports the development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials; correlative… More | ||
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) | PAR-19-358 | NCI | This Funding Opportunity Announcement (FOA) encourages research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent… More | ||
| Pre-Application Webinar for RFA-CA-20-043 "Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed) " | NOT-CA-21-015 | NCI | N/A | The NCI will hold a pre-application webinar on Thursday December 10, 2020 from 2:30 PM - 4:00 PM (ET) for the Funding Opportunity Announcement (FOA) RFA-CA-20-043 entitled " Cancer Intervention… More | |
| Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions | NOT-CA-20-044 | NCI | Notice Special Interest NOSI): Single-Cell Proteomics Interrogating Premalignant Early Malignant Lesions Notice Number: NOT-CA-20-044 Key Dates Release Date: April 09, 2020 First Available Due Date… More | ||
| Notice of Correction to Award Information in RFA-CA-19-038 "Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)" | NOT-CA-19-039 | NCI | N/A | Notice Correction Award Information RFA-CA-19-038 Development Innovative Informatics Methods Algorithms Cancer Research Management R21 Clinical Trial Optional)" Notice Number: NOT-CA-19-039 Key… More | |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) | RFA-CA-21-062 | NCI | The purpose of the NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-… More | ||
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) | PAR-20-276 | NCI | Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) along with the National Human Genome Research Institute (NHGRI) and National Institute of Dental and… More | ||
| Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) | PAR-21-278 | NCI | The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NCI R25 program is to support educational activities… More | ||
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional) | PAR-19-359 | NCI | This Funding Opportunity Announcement (FOA) encourages research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent… More |